MACKENZIE FINANCIAL CORP - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 125 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$33,781
-11.4%
33,119
+13.8%
0.00%
Q2 2023$38,116
-0.8%
29,0960.0%0.00%
Q1 2023$38,407
-24.4%
29,096
-14.0%
0.00%
Q4 2022$50,774
+41.0%
33,849
+11.6%
0.00%
Q3 2022$36,000
-7.7%
30,338
-13.2%
0.00%
Q2 2022$39,000
-35.0%
34,933
+74.9%
0.00%
Q1 2022$60,000
+13.2%
19,9690.0%0.00%
Q4 2021$53,000
-29.3%
19,969
-3.5%
0.00%
Q3 2021$75,000
+4.2%
20,700
+25.2%
0.00%
Q2 2021$72,000
+94.6%
16,531
+54.5%
0.00%
Q1 2021$37,000
-11.9%
10,700
-11.6%
0.00%
Q4 2020$42,000
+44.8%
12,1000.0%0.00%
Q3 2020$29,000
+11.5%
12,100
-14.2%
0.00%
Q2 2020$26,000
-90.5%
14,100
-81.7%
0.00%
-100.0%
Q1 2018$273,000
+9.6%
77,181
+20.5%
0.00%0.0%
Q4 2017$249,000
+118.4%
64,062
+42.5%
0.00%0.0%
Q3 2017$114,000
+8.6%
44,971
+16.8%
0.00%0.0%
Q2 2017$105,000
+87.5%
38,508
+126.5%
0.00%
Q1 2017$56,00017,0000.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 9,105,691$30,140,0005.99%
Sio Capital Management, LLC 1,888,181$6,250,0003.50%
DAFNA Capital Management LLC 473,478$1,567,0001.32%
Cormorant Asset Management, LP 2,000,000$6,620,0000.96%
Ghost Tree Capital, LLC 1,100,000$3,641,0000.68%
Rhenman & Partners Asset Management AB 1,282,000$4,243,0000.67%
Palo Alto Investors LP 4,254,623$14,083,0000.67%
NEA Management Company, LLC 3,243,150$10,375,0000.36%
Telemetry Investments, L.L.C. 170,000$563,0000.25%
NJ State Employees Deferred Compensation Plan 355,000$1,175,0000.22%
View complete list of RIGEL PHARMACEUTICALS INC shareholders